journal article·2022-09-24Open access

Li-Doped Bioactive Ceramics: Promising Biomaterials for Tissue Engineering and Regenerative Medicine

Ahmad Reza Farmani, Mohammad Ali Salmeh, Zahra Golkar, Alaa Moeinzadeh, Farzaneh Farid Ghiasi, Sara Zamani Amirabad, Mohammad Hasan Shoormeij, Forough Mahdavinezhad, Simin Momeni, Fatemeh Moradbeygi, Jafar Ai, John G. Hardy, Amir Mostafaei

Abstract

Lithium (Li) is a metal with critical therapeutic properties ranging from the treatment of bipolar depression to antibacterial, anticancer, antiviral and pro-regenerative effects. This element can be incorporated into the structure of various biomaterials through the inclusion of Li chloride/carbonate into polymeric matrices or being doped in bioceramics. The biocompatibility and multifunctionality of Li-doped bioceramics present many opportunities for biomedical researchers and clinicians. Li-doped bioceramics (capable of immunomodulation) have been used extensively for bone and tooth regeneration, and they have great potential for cartilage/nerve regeneration, osteochondral repair, and wound healing. The synergistic effect of Li in combination with other anticancer drugs as well as the anticancer properties of Li underline the rationale that bioceramics doped with Li may be impactful in cancer treatments. The role of Li in autophagy may explain its impact in regenerative, antiviral, and anticancer research. The combination of Li-doped bioceramics with polymers can provide new biomaterials with suitable flexibility, especially as bio-ink used in 3D printing for clinical applications of tissue engineering. Such Li-doped biomaterials have significant clinical potential in the foreseeable future.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Dental Implant Techniques and Outcomes · Dental materials and restorations

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Tissue Engineering and Applied Cell Sciences Department, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran 14166-34793, Iran

Tissue Engineering Department, School of Advanced Technologies in Medicine, Fasa University of Medical Sciences, Fasa 74615-168, Iran

Students’ Scientific Research Center, Tehran University of Medical Sciences, Tehran 14166-34793, Iran

Department of Biotechnology, School of Chemical Engineering, College of Engineering, University of Tehran, Tehran 14155-6619, Iran

Department of Midwifery, Firoozabad Branch, Islamic Azad University, Firoozabad 74715-117, Iran

Department of Tissue Engineering and Regenerative Medicine, Faculty of Advanced Technologies in Medicine, Iran University of Medical Sciences, Tehran 14496-14535, Iran

Cellular and Molecular Research Center, Iran University of Medical Sciences, Tehran 14496-14535, Iran

Department of Chemical Engineering, Faculty of Engineering, Yasouj University, Yasouj 75918-74934, Iran

Emergency Medicine Department, Shariati Hospital, Tehran University of Medical Sciences, Tehran 14166-34793, Iran

Anatomy Department, School of Medicine, Tehran University of Medical Sciences, Tehran 14166-34793, Iran

Department of Infertility, Velayat Hospital, Qazvin University of Medical Sciences, Qazvin 34199-15315, Iran

Chemistry Department, Faculty of Science, Shahid Chamran University of Ahvaz, Ahvaz 83151-61355, Iran

Department of Pharmaceutical Biotechnology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz 71348-14336, Iran

Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz 71348-14336, Iran

Department of Chemistry, Faraday Building, Lancaster University, Lancaster LA1 4YB, UK

Materials Science Institute, Lancaster University, Lancaster LA1 4YW, UK

Department of Mechanical, Materials, and Aerospace Engineering, Illinois Institute of Technology, 10 W 32nd Street, Chicago, IL 60616, USA

References (100+)

Show source-provided references
1. Application of Platelet Rich Fibrin in Tissue Engineering: Focus on Bone Regeneration10.1080/09537104.2020.1869710 ↗
2. Human endometrial stem cells differentiation into functional hepatocyte-like cells10.1002/cbin.10278 ↗
3. Natural biomacromolecule based composite scaffolds from silk fibroin, gelatin and chitosan toward tissue engineering applications10.1016/j.ijbiomac.2019.11.003 ↗
4. Thermoresponsive polyurethane/siloxane membrane for wound dressing and cell sheet transplantation: In-vitro and in-vivo studies10.1016/j.msec.2016.07.067 ↗
5. Polyurethane-Polycaprolactone Blend Patches: Scaffold Characterization and Cardiomyoblast Adhesion, Proliferation, and Function10.1021/acsbiomaterials.8b00848 ↗
6. Preparation of fibrin gel scaffolds containing MWCNT/PU nanofibers for neural tissue engineering10.1002/jbm.a.36596 ↗
7. Human menstrual blood stem cell-derived granulosa cells participate in ovarian follicle formation in a rat model of premature ovarian failure in vivo10.1089/cell.2019.0020 ↗
8. Three-dimensional co-culture of human spermatogonial stem cells with Sertoli cells in soft agar culture system supplemented by growth factors and Laminin10.1016/j.acthis.2020.151572 ↗
9. The air-liquid interface culture of the mechanically isolated seminiferous tubules embedded in agarose or alginate improves in vitro spermatogenesis at the expense of attenuating their integrity10.1007/s11626-020-00437-6 ↗
10. Isolation, identification and differentiation of human spermatogonial cells on three-dimensional decellularized sheep testis10.1016/j.acthis.2020.151623 ↗
11. Tissue engineering; strategies, tissues, and biomaterials10.1080/02648725.2018.1430464 ↗
12. Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia10.3389/fbioe.2020.00083 ↗
13. A decade of progress in tissue engineering10.1038/nprot.2016.123 ↗
14. Pina, S., Ribeiro, V.P., Marques, C.F., Maia, F.R., Silva, T.H., Reis, R.L., and Oliveira, J.M. (2019). Scaffolding strategies for tissue engineering and regenerative medicine applications. Materials, 12.10.3390/ma12111824 ↗
15. Recent advances in stem cell therapeutics and tissue engineering strategies10.1186/s40824-018-0148-4 ↗
16. Combining stem cells and biomaterial scaffolds for constructing tissues and cell delivery10.3233/STJ-180001 ↗
17. A Concise Review: The Role of Stem Cells in Cancer Progression and Therapy10.2147/OTT.S260391 ↗
18. Unhealthy stem cells: When health conditions upset stem cell properties10.1159/000489440 ↗
19. Endometriosis: A role for stem cells
20. The Potential Relationship Between Different Human Female Reproductive Disorders and Sperm Quality in Female Genital Tract10.1007/s43032-021-00520-7 ↗
21. Biomaterials for tissue engineering10.1007/s10439-013-0859-6 ↗
22. State-of-Art Functional Biomaterials for Tissue Engineering10.3389/fmats.2019.00172 ↗
23. Polymeric Biomaterials in Tissue Engineering10.1203/01.pdr.0000305937.26105.e7 ↗
24. Bioceramics and Scaffolds: A Winning Combination for Tissue Engineering10.3389/fbioe.2015.00202 ↗
25. Nanocomposite hydrogels for tissue engineering applications10.1039/D0NR03785K ↗
26. Prasad, K., Bazaka, O., Chua, M., Rochford, M., Fedrick, L., Spoor, J., Symes, R., Tieppo, M., Collins, C., and Cao, A. (2017). Metallic Biomaterials: Current Challenges and Opportunities. Materials, 10.10.3390/ma10080884 ↗
27. Prakasam, M., Locs, J., Salma-Ancane, K., Loca, D., Largeteau, A., and Berzina-Cimdina, L. (2017). Biodegradable Materials and Metallic Implants—A Review. J. Funct. Biomater., 8.10.3390/jfb8040044 ↗
28. Porous Biodegradable Metals for Hard Tissue Scaffolds: A Review10.1155/2012/641430 ↗
29. Bazaka, O. (2021). Metallic Implants for Biomedical Applications. Metallic Implants for Biomedical Applications, Royal Society of Chemistry.10.1039/9781788019828-00001 ↗
30. Bhaskar, B., Rao, P.S., Kasoju, N., Nagarjuna, V., and Baadhe, R.R. (2021). Metallic Biomaterials in Tissue Engineering: Retrospect and Prospects. Biomaterials in Tissue Engineering and Regenerative Medicine: From Basic Concepts to State of the Art Approaches, Springer.10.1007/978-981-16-0002-9 ↗
31. A review of bioceramic porous scaffolds for hard tissue applications: Effects of structural features10.1016/j.ceramint.2020.03.192 ↗
32. Bioceramics to regulate stem cells and their microenvironment for tissue regeneration10.1016/j.mattod.2018.07.016 ↗
33. Bioactive Materials for Soft Tissue Repair10.3389/fbioe.2021.613787 ↗
34. Black Bioceramics: Combining Regeneration with Therapy10.1002/adma.202005140 ↗
35. Silicate bioceramics: From soft tissue regeneration to tumor therapy10.1039/C9TB01467E ↗
36. Bioceramics: From Concept to Clinic10.1111/j.1151-2916.1991.tb07132.x ↗
37. Bioactive Glass and Glass-Ceramic Scaffolds for Bone Tissue Engineering10.3390/ma3073867 ↗
38. Eliaz, N., and Metoki, N. (2017). Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications. Materials, 10.10.3390/ma10040334 ↗
39. Bioceramics processing routes and mechanical evaluation10.2109/jcersj.110.601 ↗
40. Kokubo, T. (2008). 4—Mechanical properties of bioceramics. Bioceramics and their Clinical Applications, Woodhead Publishing.10.1533/9781845694227 ↗
41. Bioceramics and bone healing10.1302/2058-5241.3.170056 ↗
42. Kokubo, T. (2008). Bioceramics and Their Clinical Applications, Elsevier.10.1533/9781845694227 ↗
43. Glasses, B. (2019). An Introduction to Bioceramics, World Scientific. Structure.
44. Hench, L.L. (1993). An Introduction to Bioceramics, World Scientific.10.1142/2028 ↗
45. Structure and functionalization of mesoporous bioceramics for bone tissue regeneration and local drug delivery
46. Bioceramic Drug Delivery System for Cancer Treatment and Regenerative Medicine10.4028/www.scientific.net/KEM.696.245 ↗
47. Three-Dimensional-Printed Bioceramic Scaffolds with Osteogenic Activity for Simultaneous Photo/Magnetothermal Therapy of Bone Tumors10.1021/acsbiomaterials.9b01095 ↗
48. Application of hydroxyapatite nanoparticles in tumor-associated bone segmental defect10.1126/sciadv.aax6946 ↗
49. A critical review of bioceramics for magnetic hyperthermia10.1111/jace.17861 ↗
50. Metallic ions as therapeutic agents in tissue engineering scaffolds: An overview of their biological applications and strategies for new developments10.1098/rsif.2011.0611 ↗
51. Current advances concerning the most cited metal ions doped bioceramics and silicate-based bioactive glasses for bone tissue engineering10.1016/j.ceramint.2020.09.213 ↗
52. Enhancement of the Biological and Mechanical Performances of Sintered Hydroxyapatite by Multiple Ions Doping10.3389/fmats.2020.00224 ↗
53. Enhancing biological activity of bioactive glass scaffolds by inorganic ion delivery for bone tissue engineering10.1016/j.cobme.2019.02.002 ↗
54. Towards a unified understanding of lithium action in basic biology and its significance for applied biology10.1007/s00232-017-9998-2 ↗
55. Lithium: A review of pharmacology, clinical uses, and toxicity10.1016/j.ejphar.2014.06.042 ↗
56. Solar system abundances and condensation temperatures of the elements10.1086/375492 ↗
57. Lithium in unipolar depression and the prevention of suicide
58. The history of lithium therapy10.1111/j.1399-5618.2009.00706.x ↗
59. A brief history of lithium treatment in psychiatry10.4088/PCC.17br02140 ↗
60. Lamotrigine in the maintenance treatment of bipolar disorder
61. Influence of ionic conditions on cell differentiation and morphogenesis of the cellular slime molds10.1111/j.1440-169X.1970.00217.x ↗
62. A molecular mechanism for the effect of lithium on development10.1073/pnas.93.16.8455 ↗
63. Molecular targets of lithium action10.1046/j.1601-5215.2003.00049.x ↗
64. Clinical pharmacokinetics of lithium10.1002/j.1552-4604.1994.tb01994.x ↗
65. Ishii, N., Terao, T., and Hirakawa, H. (2021). The Present State of Lithium for the Prevention of Dementia Related to Alzheimer’s Dementia in Clinical and Epidemiological Studies: A Critical Review. Int. J. Environ. Res. Public Health, 18.10.3390/ijerph18157756 ↗
66. Long-term effects of lithium on renal, thyroid, and parathyroid function: A retrospective analysis of laboratory data10.1016/S0140-6736(14)61842-0 ↗
67. Lithium side effects and toxicity: Prevalence and management strategies10.1186/s40345-016-0068-y ↗
68. Reversible hand tremors, downbeat nystagmus, and an unsteady gait with nontoxic lithium level10.1002/ccr3.1981 ↗
69. Practice guideline for the treatment of partients with schizophrenia
70. Therapeutic drug monitoring of psychotropic medications10.1111/j.1365-2125.2001.00174.x ↗
71. Lithium tremor revisited: Pathophysiology and treatment10.1111/acps.12171 ↗
72. Lithium-induced periodic alternating nystagmus10.1212/01.WNL.0000042787.51461.D1 ↗
73. Female vulnerability for thyroid function abnormality in bipolar disorder: Role of lithium treatment10.1111/bdi.12163 ↗
74. Lithium treatment and potential long-term side effects: A systematic review of the literature
75. Lithium treatment and cancer incidence in bipolar disorder10.1111/bdi.12361 ↗
76. Systems biology understanding of the effects of lithium on cancer10.3389/fonc.2019.00296 ↗
77. Lithium Inhibits Glycogen Synthase Kinase-3 by Competition for Magnesium10.1006/bbrc.2000.4169 ↗
78. Lithium inhibits carcinoid cell growth in vitro
79. In vitro effects of lithium chloride on TNFα and IL-6 production by monocytes from breast cancer patients10.1179/joc.1997.9.3.219 ↗
80. Biphasic dose-dependent effect of lithium chloride on survival of human hormone-dependent breast cancer cells (MCF-7)10.1007/s12011-012-9510-x ↗
81. Lithium increases radiosensitivity by abrogating DNA repair in breast cancer spheroid culture
82. O’Donovan, T.R., Rajendran, S., O’Reilly, S., O’Sullivan, G.C., and McKenna, S.L. (2015). Lithium modulates autophagy in esophageal and colorectal cancer cells and enhances the efficacy of therapeutic agents in vitro and in vivo. PLoS ONE, 10.10.1371/journal.pone.0134676 ↗
83. Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells
84. Lithium chloride suppresses colorectal cancer cell survival and proliferation through ROS/GSK-3β/NF-κB signaling pathway10.1155/2014/241864 ↗
85. PTEN overexpression cooperates with lithium to reduce the malignancy and to increase cell death by apoptosis via PI3K/Akt suppression in colorectal cancer cells10.1002/jcb.25294 ↗
86. Lithium chloride increases sensitivity to photon irradiation treatment in primary mesenchymal colon cancer cells
87. Lithium inhibits proliferation of human esophageal cancer cell line Eca-109 by inducing a G2/M cell cycle arrest10.3748/wjg.14.3982 ↗
88. A metabolic inhibitory cocktail for grave cancers: Metformin, pioglitazone and lithium combination in treatment of pancreatic cancer and glioblastoma multiforme10.1007/s10528-016-9754-9 ↗
89. Lithium chloride and inhibition of glycogen synthase kinase 3β as a potential therapy for serous ovarian cancer10.1097/IGC.0b013e31827cfecb ↗
90. Lithium and an EPAC-specific inhibitor ESI-09 synergistically suppress pancreatic cancer cell proliferation and survival10.1093/abbs/gmx045 ↗
91. Combined treatment of androgen-independent prostate cancer cell line DU145 with chemotherapeutic agents and lithium chloride: Effect on growth arrest and/or apoptosis
92. Lithium chloride has a biphasic effect on prostate cancer stem cells and a proportional effect on midkine levels10.3892/ol.2016.4946 ↗
93. Lithium suppresses cell proliferation by interrupting E2F–DNA interaction and subsequently reducing S–phase gene expression in prostate cancer10.1002/pros.20586 ↗
94. Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma
95. Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride10.1016/j.jss.2008.08.004 ↗
96. Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: The effect of pre-treatment with furosemide and furosemide plus lithium10.1007/s00259-009-1254-2 ↗
97. The Role of Lithium in Management of Endocrine Tumors—A Comprehensive Review10.3389/fonc.2019.01092 ↗
98. Lithium enhances TRAIL-induced apoptosis in human lung carcinoma A549 cells10.1007/s10534-012-9607-x ↗
99. Lithium modulates cancer cell growth, apoptosis, gene expression and cytokine production in HL-60 promyelocytic leukaemia cells and their drug-resistant sub-clones10.1007/s12011-012-9438-1 ↗
100. Lithium chloride promotes apoptosis in human leukemia NB4 cells by inhibiting glycogen synthase kinase-3 beta10.7150/ijms.12429 ↗